In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase

Molecular Pharmaceutics

Volumn 7, Issue 3, 2010, Pages 894-904

  Liu, Huanxiang ^a   Yao, Xiaojun ^a   Wang, Chengqi ^a   Han, Jian ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

2009 H1N1 influenza A virus; Drug resistance; Molecular dynamics simulation; Molecular mechanics generalized Born surface area (MM GBSA); Neuraminidase inhibitors

Indexed keywords

OSELTAMIVIR; SIALIC ACID; VIRUS SIALIDASE; ZANAMIVIR;

ANTIVIRAL RESISTANCE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING; EPIDEMIC; INFLUENZA VIRUS A H1N1; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; THREE DIMENSIONAL IMAGING; VIRUS MORPHOLOGY;

DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR DYNAMICS SIMULATION; NEURAMINIDASE; OSELTAMIVIR; ZANAMIVIR;

EID: 77953267929     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100041b     Document Type: Article

References (42)

1. http://www.who.int/csr/don/2010-01-08/en/index.html, accessed Jan 9, 2010.
2. Garten, R. J.; Davis, C. T.; Russell, C. A.; Shu, B.; Lindstrom, S.; Balish, A.; Sessions, W. M.; Xu, X.; Skepner, E.; Deyde, V.; Okomo-Adhiambo, M.; Gubareva, L.; Barnes, J.; Smith, C. B.; Emery, S. L.; Hillman, M. J.; Rivailler, P.; Smagala, J.; de Graaf, M.; Burke, D. F.; Fouchier, R. A.; Pappas, C.; Alpuche-Aranda, C. M.; L-pez-Gatell, H.; Olivera, H.; L-pez, I.; Myers, C. A.; Faix, D.; Blair, P. J.; Yu, C.; Keene, K. M.; Dotson, P. D., Jr; Boxrud, D.; Sambol, A. R.; Abid, S. H.; St George, K.; Bannerman, T.; Moore, A. L.; Stringer, D. J.; Blevins, P.; Demmler-Harrison, G. J.; Ginsberg, M.; Kriner, P.; Waterman, S.; Smole, S.; Guevara, H. F.; Belongia, E. A.; Clark, P. A.; Beatrice, S. T.; Donis, R.; Katz, J.; Finelli, L.; Bridges, C. B.; Shaw, M.; Jernigan, D. B.; Uyeki, T. M.; Smith, D. J.; Klimov, A. I.; Cox, N. J. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans Science 2009, 325, 197-201
3. CDC, Antiviral Drugs and H1N1 Flu (Swine Flu). Available from: http://www.cdc.gov/h1n1flu/antiviral.htm (accessed May 2009).
4. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5832a3.htm, accessed Jan. 9, 2010.
5. Condra, J. H.; Schleif, W. A.; Blahy, O. M.; Gabryelski, L. J.; Graham, D. J.; Quintero, J. C.; Rhodes, A.; Robbins, H. L.; Roth, E.; Shivaprakash, M.; Titus, D.; Yang, T.; Teppler, H.; Squires, K. E.; Deutsch, P. J.; Emini, E. A. Invivo emergence of HIV-1 variants resistant to multiple protease inhibitors Nature 1995, 374, 569-571
6. Kaplan, A. H.; Michael, S. F.; Wehbie, R. S.; Knigge, M. F.; Paul, D. A.; Everitt, L.; Kempf, D. J.; Norbeck, D. W.; Erickson, J. W.; Swanstrom, R. Selection of multiple human-immunodeficiency-virus type-1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 5597-5601
7. Cao, Z. W.; Han, L. Y.; Zheng, C. J.; Ji, Z. L.; Chen, X.; Lin, H. H.; Chen, Y. Z. Computer prediction of drug resistance mutations in proteins Drug Discovery Today 2005, 10, 521-529
8. Chachra, R.; Rizzo, R. C. Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations J. Chem. Theory Comput. 2008, 4, 1526-1540
9. Hou, T.; McLaughlin, W. A.; Wang, W. Evaluating the potency of HIV-1 protease drugs to combat resistance Proteins 2008, 71, 1163-1174
10. Zhang, J.; Hou, T.; Wang, W.; Liu, J. S. Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 1321-1326
11. Srinivasan, J.; Cheatham, T. E.; Cieplak, P.; Kollman, P. A.; Case, D. A. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices J. Am. Chem. Soc. 1998, 120, 9401-9409 (Pubitemid 28452628)
12. Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; Donini, O.; Cieplak, P.; Srinivasan, J.; Case, D. A.; Cheatham, T. E. Calculating structures and free energies of complex molecules: combining molecular Molecular mechanics and continuum models Acc. Chem. Res. 2000, 33, 889-897
13. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations J. Comput. Chem. 2003, 24, 1999-2012
14. Lee, M. C.; Duan, Y. Distinguish protein decoys by using a scoring function based on a new AMBER force field, short molecular dynamics simulations, and the generalized born solvent model Proteins: Struct., Funct., Bioinf. 2004, 55, 620-634
15. Tsui, V.; Case, D. A. Theory and applications of the generalized born solvation model in macromolecular simulations Biopolymers 2000, 56, 275-291 (Pubitemid 34105875)
16. Onufriev, A.; Bashford, D.; Case, D. A. Modification of the generalized Born model suitable for macromolecules J. Phys. Chem. B 2000, 104, 3712-3720
17. Feig, M.; Brooks, C. L., III. Evaluating CASP4 predictions with physical energy functions Proteins 2002, 49, 232-245
18. Gourmala, C.; Luo, Y.; Barbault, F.; Zhang, Y.; Ghalem, S.; Maurel, F.; Fan, B. Elucidation of the LewisX-LewisX carbohydrate interaction with molecular dynamics simulations: A glycosynapse model J. Mol. Struct. THEOCHEM 2007, 821, 22-29
19. Afshan Shaikh, S.; Jayaram, B. A Swift All-Atom Energy-Based Computational Protocol to Predict DNA-Ligand Binding Affinity and δTm J. Med. Chem. 2007, 50, 2240-2244
20. Gohlke, H.; Kiel, C.; Case, D. A. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes J. Mol. Biol. 2003, 330, 891-913
21. Prime, version 2.0; Schr̈dinger, LLC: New York, NY, 2008.
22. Collins, P. J.; Haire, L. F.; Lin, Y. P.; Liu, J.; Russell, R. J.; Walker, P. A.; Skehel, J. J.; Martin, S. R.; Hay, A. J.; Gamblin, S. J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants Nature 2008, 453, 1258-1261
23. http://www.ncbi.nlm.nih.gov/protein/237511824, accessed Jan 9, 2010.
24. Case, D. A.; Cheatham, T. E.; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M.; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R. J. The Amber biomolecular simulation programs J. Comput. Chem. 2005, 26, 1668-1688
25. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A., Jr.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.; Challacombe, M.; Gill, P. M. W.; Johnson, B. G.; Chen, W.; Wong, M. W.; Andres, J. L.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian 98, revision A.9; Gaussian Inc.: Pittsburgh, PA, 1998.
26. Bayly, C. I.; Cieplak, P.; Cornell, W. D.; Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges - the Resp model J. Phys. Chem. 1993, 97, 10269-10280
27. Wang, J. M.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of a general amber force field J. Comput. Chem. 2004, 25, 1157-1174
28. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G. M.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J. M.; Kollman, P. A. point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations J. Comput. Chem. 2003, 24, 1999-2012
29. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 1983, 79, 926-935
30. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T. A smooth particle mesh Ewald method J. Chem. Phys. 1995, 103, 8577-9593
31. Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 1977, 23, 327-341
32. Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; DiNola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath J. Chem. Phys. 1984, 81, 3684-3690
33. Sitkoff, D.; Sharp, K. A.; Honig, B. Accurate calculation of hydration free energies using macroscopic solvent models J. Phys. Chem. 1994, 98, 1978-1988
34. McQuarrie, D. A. Statistical thermodynamics; Harper & Row: New York, 1973.
35. Wang, W.; Kollman, P. A. Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 14937-14942
36. Simossis, V. A.; Heringa, J. PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information Nucleic Acids Res. 2005, 33, W289-W294
37. Govorkova, E. A.; Leneva, I. A.; Goloubeva, O. G.; Bush, K.; Webster, R. G. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses Antimicrob. Agents Chemother. 2001, 45, 2723-2732
38. Bantia, S.; Parker, C. D.; Ananth, S. L.; Horn, L. L.; Andries, K.; Chand, P.; Kotian, P. L.; Dehghani, A.; El-Kattan, Y.; Lin, T.; Hutchison, T. L.; Montgomery, J. A.; Kellog, D. L.; Babu, Y. S. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir Antimicrob. Agents Chemother. 2001, 45, 1162-1167
39. Boivin, G; Goyette, N. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors Antiviral Res. 2002, 54, 143-147
40. Masukawa, K.; Kollman, P. A.; Kuntz, I. D. Investigation of Neuraminidase-Substrate Recognition Using Molecular Dynamics and Free Energy Calculations J. Med. Chem. 2003, 46, 5628-5637
41. Gubareva, L. V.; Kaiser, L.; Hayden, F. G. Influenza virus neuraminidase inhibitors Lancet 2000, 355, 827-35
42. Kiso, M.; Mitamura, K.; Sakai-Tagawa, Y.; Shiraishi, K.; Kawakami, C.; Kimura, K.; Hayden, F. G.; Sugaya, N.; Kawaoka, Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 2004, 364, 759-65